Excess Adiposity as a Chronic Disease: Causes, Impact, and Management Strategies

Obesity is a chronic, relapsing medical condition characterized by an excessive accumulation of body fat that impairs health. It is not merely a cosmetic concern, but a complex disease involving biological, behavioral, environmental, and social mechanisms. Obesity substantially increases the risk of cardiovascular disease, metabolic disorders, respiratory conditions, musculoskeletal disease, and certain malignancies, while also affecting psychological well-being and quality of life.

What Is Obesity?

Obesity is defined by an abnormal or excessive accumulation of adipose tissue that presents a risk to health. In clinical practice, body mass index is widely used as a screening tool to classify weight status in adults. Although body mass index does not directly measure body fat, it correlates reasonably well with total adiposity and disease risk at the population level.

Beyond total body fat, fat distribution is clinically relevant. Central or visceral adiposity, reflected by increased waist circumference, is strongly associated with insulin resistance, dyslipidemia, and cardiovascular disease. For this reason, waist circumference and, in some settings, body fat percentage are used alongside body mass index to refine risk assessment.

Clinical Classification and Assessment

Body mass index categories are commonly used to stratify health risk:

• Underweight: below 18.5

• Healthy weight: 18.5–24.9

• Overweight: 25.0–29.9

• Obesity: 30.0 and above

Ethnic background modifies risk thresholds, as individuals of Asian descent may develop metabolic complications at lower body mass index values. Waist circumference measurements provide additional prognostic information, particularly regarding cardiometabolic risk.

Causes and Pathophysiology of Obesity

Obesity develops when long-term energy intake exceeds energy expenditure, leading to positive energy balance and fat storage. However, this simplified model does not capture the complexity of the disease.

Genetic factors influence appetite regulation, satiety signaling, fat distribution, and basal metabolic rate. These inherited traits interact with modern environments characterized by easy access to calorie-dense foods and reduced physical activity.

Hormonal and metabolic mechanisms play a central role. Dysregulation of appetite-controlling hormones, alterations in insulin sensitivity, and changes in adipokine secretion contribute to weight gain and difficulty maintaining weight loss. Chronic stress, sleep deprivation, and circadian rhythm disruption further exacerbate these processes.

Environmental and socioeconomic factors shape dietary patterns and physical activity opportunities. Limited access to healthy foods, unsafe environments for physical activity, and occupational sedentarism significantly increase obesity risk.

Risk Factors

Several factors increase susceptibility to obesity:

Family history and shared lifestyle habits
High-calorie diets rich in ultra-processed foods and sugar-sweetened beverages
Sedentary behavior and prolonged screen time
Certain medical conditions affecting hormonal balance or mobility
Medications that alter appetite, metabolism, or fluid balance
Psychological stress and disordered sleep patterns
Life stages such as pregnancy, menopause, and aging

These factors often coexist and reinforce each other, making obesity a multifactorial condition rather than the result of individual behavior alone.

Health Consequences and Complications

Obesity is associated with a broad range of medical complications. Excess adipose tissue promotes chronic low-grade inflammation, endothelial dysfunction, and metabolic derangements.

Cardiovascular disease risk increases through hypertension, dyslipidemia, and atherosclerosis. Obesity is a major driver of insulin resistance and type 2 diabetes. Respiratory complications include obstructive sleep apnea and reduced pulmonary function.

Musculoskeletal strain contributes to osteoarthritis, chronic back pain, and reduced mobility. Excess fat deposition in the liver can progress from steatosis to inflammation and fibrosis. Obesity also increases the risk of multiple hormone-sensitive and gastrointestinal cancers.

Infectious disease outcomes may be worse in individuals with obesity, as observed in severe viral respiratory infections. Beyond physical health, obesity affects mental health through stigma, depression, reduced self-esteem, and social isolation.

Diagnosis and When to Seek Medical Care

Clinical evaluation of obesity includes anthropometric measurements, metabolic screening, and assessment of obesity-related complications. Medical consultation is recommended when excess weight is associated with health concerns, functional limitations, or difficulty achieving sustainable weight loss.

Early evaluation allows identification of reversible contributors and timely intervention to reduce long-term morbidity.

Management and Treatment Approaches

Obesity management requires a long-term, individualized strategy. Lifestyle interventions focusing on nutritional quality, portion control, physical activity, and behavioral modification form the foundation of treatment.

Structured dietary approaches aim to reduce caloric intake while preserving nutritional adequacy. Physical activity improves energy expenditure, metabolic health, and cardiovascular fitness, even in the absence of significant weight loss.

Pharmacological therapies may be considered in selected patients to support appetite regulation and metabolic control. In cases of severe obesity or obesity with significant comorbidities, metabolic and bariatric procedures may be appropriate, offering durable weight loss and improvement in obesity-related diseases.

Sustainable success depends on ongoing medical follow-up, psychological support, and addressing environmental and social determinants of health.

Scientific references

1. World Health Organization. Obesity and overweight. WHO Fact Sheets.

2. Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. The Lancet Diabetes & Endocrinology. 2017;5(9):716–723.

3. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673–689.

4. Blüher M. Obesity: global epidemiology and pathogenesis. Nature Reviews Endocrinology. 2019;15(5):288–298.

5. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. Journal of Clinical Endocrinology & Metabolism. 2004;89(6):2595–2600.

6. Pi-Sunyer X. The medical risks of obesity. Postgraduate Medicine. 2009;121(6):21–33.